JO
NEO icon

John Overdeck’s NeoGenomics NEO Stock Holding History

John Overdeck’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,200
Closed -$396K – 4660
2021
Q3 		$396K Sell
8,200
-600
-7% -$27.8K ﹤0.01% 3448
2021
Q2 		$397K Buy
8,800
+1,400
+19% +$62K ﹤0.01% 3289
2021
Q1 		$357K Buy
+7,400
New +$385K ﹤0.01% 3204

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

John Overdeck's NEO Position: Q2 2026 in Review

John Overdeck opened a new position in NeoGenomics (NEO) in Q2 2026: 39,455 shares worth $576K. The stake represents ﹤0.01% of the portfolio and ranks #4049 among its holdings. This is a return to the name: John Overdeck previously reported a position in NEO as recently as Q4 2025.

John Overdeck first reported a position in NEO in Q3 2014 and has held it in 20 quarters since. The position peaked at $11.9M in Q2 2022. 265 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • John Overdeck held 39,455 shares of NeoGenomics worth $576K as of Q2 2026.
  • NeoGenomics was a new John Overdeck position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4049 holding.
  • John Overdeck first reported a position in NeoGenomics in Q3 2014 and has held it in 20 quarters since.
  • John Overdeck's NeoGenomics position peaked at $11.9M in Q2 2022.
  • 265 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.